NRG Therapeutics Begins Human PET Study to Measure Brain Exposure of Experimental ALS and Parkinson’s Drug

Nuclio Media

Read more

NRG Therapeutics Announces a PET Biodistribution Trial of Lead Clinical Asset...NRG Therapeutics launches brain-tracking study for new neurodegenerative dr...